Connect
Pancreatic Cancer Q&A with Dr. Stauffer, Mayo Surgeon: May 29
Allow me to introduce you to Dr. John Stauffer, a hepatobiliary and pancreas surgical oncologist at Mayo Clinic in Florida, one of the country's highest-volume surgical programs for advanced pancreatic cancer.
On Thursday, May 29 from 1:30-2:30pm ET, Dr. Stauffer will host a Q&A about surgical management of pancreatic cancer.
After a pancreatic cancer diagnosis, many people have questions about treatment options, including surgical and nonsurgical approaches. You may also want to know how an integrated team – including surgical oncology, medical oncology, radiation oncology and gastroenterology specialists – works together to prevent further cancer complications and preserve your quality of life.
Please note that this hour-long Q&A is for informational purposes only, and any concerns you have should be addressed to your treating physician. If you would like to learn about pancreas cancer care at our integrated program in Florida, please visit this page for information.
Submit your questions in advance in the comments below and Dr. Stauffer will reply during the hour-long Q&A event. See you back here on May 29.
Go ahead, ask away!
Like
Helpful
HugInterested in more discussions like this? Go to the Pancreatic Cancer Support Group.
Connect
My pancreatic cancer has metastsized to the liver and I have started chemo Rx. If the liver nodules resolve would I then be a surgical candidate? Is there a pathway from non-surgical to surgical treatment?
-
Like -
Helpful -
Hug
2 ReactionsGiven the high rate of recurrence after Whipple, what are your thoughts on total pancreatectomy, especially for younger patients or patients with mutations predisposing them to more PDAC development?
-
Like -
Helpful -
Hug
3 ReactionsAfter ⅔ of the pancreas was removed with good margins, if there is some sign of FDG uptake at the resected area, is it advisable to go in and cut more of the pancreas or remove the entire pancreas? There is no sign of spread anywhere else in recent PET scan and MRI but could the cancer be already in the blood? Chemo is ongoing from Feb 2024. Surgery was Dec 2023.
When someone is NED, at what point do you feel the person is cured? 2 years? 5 years?
When someone is termed NED, do you recommend continuing interval chemo and for how long?
-
Like -
Helpful -
Hug
3 ReactionsHello Dr! Thank you for doing this Q&A, as it is much appreciated.
If one has 1 or 2 nodules say in segment 5 of liver, which I’ve been told is a good candidate area for surgery as far as not impacting other organs, why don’t more drs remove the lesions or nodules surgically since it’s a permanent solution, rather than recommend chemo or SBRT as most do?
-
Like -
Helpful -
Hug
2 ReactionsHi all, this event is hosted in text only. No link. Dr. John Stauffer will reply to your question in the comments. He will do so in the hour from 1:30-2:30pm ET on May 29th.
Return here on or after May 29th to see his replies.
cc: @mnewland99 @56pan @dalegantous
-
Like -
Helpful -
Hug
4 ReactionsThank you for this opportunity!
Our experience is that pdac is slow growing and often not found until it has grown/spread. Our surgeon said that it was most likely here for several years before presenting symptoms.
For those lucky enough to find it early and undergo surgery and treatment, I'm wondering why then is the risk of recurrence within two years so high if it's a slow growing cancer?
-
Like -
Helpful -
Hug
3 ReactionsFor lesions in section 5 and 8 of the liver, can you compare surgery vs SBRT vs histotripsy as treatment options? Does Jacksonville Mayo perform histotripsy? Thank you!
-
Like -
Helpful -
Hug
1 Reaction- A Study to Evaluate the NanoKnife SYstem for Stage 3 Pancreatic Cancer https://www.mayo.edu/research/clinical-trials/cls-20509963
Dr. Stauffer, what can you share with us about your study and use of nanoknife for the treatment of pancreatic cancer?
-
Like -
Helpful -
Hug
1 ReactionApologies if this is addressed in study, but have you seen a lower recurrence rate with Nanoknife vs total Pancreatectomy? Are you an advocate for adjuvant chemotherapy for all surgical patients, irregardless of pathology report findings or type of surgery?